Does fetal exposure to SSRIs or maternal depression impact infant growth?

American Journal of Psychiatry

Volumn 170, Issue 5, 2013, Pages 485-493

  Wisner, Katherine L ^a   Bogen, Debra L ^a   Sit, Dorothy ^a   McShea, Mary ^a   Hughes, Carolyn ^a   Rizzo, David ^a   Confer, Andrea ^a   Luther, James ^a   Eng, Heather ^a   Wisniewski, Stephen W ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN UPTAKE INHIBITOR; ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; ARTICLE; BIRTH WEIGHT; BODY HEIGHT; BODY MASS; CHILD GROWTH; CONTROLLED STUDY; FEMALE; HEAD CIRCUMFERENCE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; OBSERVATIONAL STUDY; PERINATAL DRUG EXPOSURE; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROSPECTIVE STUDY; BODY SIZE; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; FETUS DEVELOPMENT; GROWTH, DEVELOPMENT AND AGING; HEAD; MALE; NEWBORN; PREGNANCY; PRENATAL EXPOSURE;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BODY SIZE; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; FETAL DEVELOPMENT; HEAD; HUMANS; INFANT; INFANT, NEWBORN; MALE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROSPECTIVE STUDIES; SEROTONIN UPTAKE INHIBITORS;

MLCS; MLOWN;

EID: 84879458811     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2012.11121873     Document Type: Article

References (36)

1. Gaynes BN, Gavin N, Meltzer-Brody S, Lohr KN, Swinson T, Gartlehner G, Brody S, Miller WC: Perinatal depression: prevalence, screening accuracy, and screening outcomes. Evid Rep Technol Assess (Summ) 2005; 119: 1-8
2. Bennett IM, Marcus SC, Palmer SC, Coyne JC: Pregnancy-related discontinuation of antidepressants and depression care visits among Medicaid recipients. Psychiatr Serv 2010; 61: 386-391
3. Suri R, Altshuler L, Hellemann G, Burt VK, Aquino A, Mintz J: Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth. Am J Psychiatry 2007; 164: 1206-1213
4. Cohen LS, Altshuler LL, Harlow BL, Nonacs R, Newport DJ, Viguera AC, Suri R, Burt VK, Hendrick V, Reminick AM, Loughead A, Vitonis AF, Stowe ZN: Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA 2006; 295: 499-507
5. Bonari L, Pinto N, Ahn E, Einarson A, Steiner M, Koren G: Perinatal risks of untreated depression during pregnancy. Can J Psychiatry 2004; 49: 726-735
6. Grote V, Vik T, von Kries R, Luque V, Socha J, Verduci E, Carlier C, Koletzko B; European Childhood Obesity Trial Study Group: Maternal postnatal depression and child growth: a European cohort study. BMC Pediatr 2010; 10: 14
7. Wisner KL, Sit DK, Hanusa BH, Moses-Kolko EL, Bogen DL, Hunker DF, Perel JM, Jones-Ivy S, Bodnar LM, Singer LT: Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes. Am J Psychiatry 2009; 166: 557-566
8. Grote NK, Bridge JA, Gavin AR, Melville JL, Iyengar S, Katon WJ: A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch Gen Psychiatry 2010; 67: 1012-1024
9. Teixeira JM, Fisk NM, Glover V: Association between maternal anxiety in pregnancy and increased uterine artery resistance index: cohort based study. BMJ 1999; 318: 153-157
10. Christian LM, Franco A, Iams JD, Sheridan J, Glaser R: Depressive symptoms predict exaggerated inflammatory responses to an in vivo immune challenge among pregnant women. Brain Behav Immun 2010; 24: 49-53
11. Ertel KA, Koenen KC, Rich-Edwards JW, Gillman MW: Maternal depressive symptoms not associated with reduced height in young children in a US prospective cohort study. PLoS ONE 2010; 5:e13656
12. Santos IS, Matijasevich A, Domingues MR, Barros AJ, Barros FC: Long-lasting maternal depression and child growth at 4 years of age: a cohort study. J Pediatr 2010; 157: 401-406
13. Ramsay M, Gisel EG, McCusker J, Bellavance F, Platt R: Infant sucking ability, non-organic failure to thrive, maternal characteristics, and feeding practices: a prospective cohort study. Dev Med Child Neurol 2002; 44: 405-414
14. Källén B: Neonate characteristics after maternal use of antidepressants in late pregnancy. Arch Pediatr Adolesc Med 2004; 158: 312-316
15. Lattimore KA, Donn SM, Kaciroti N, Kemper AR, Neal CR Jr, Vazquez DM: Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and effects on the fetus and newborn: a meta-analysis. J Perinatol 2005; 25: 595-604
16. El Marroun H, Jaddoe VW, Hudziak JJ, Roza SJ, Steegers EA, Hofman A, Verhulst FC, White TJ, Stricker BH, Tiemeier H: Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes. Arch Gen Psychiatry 2012; 69: 706-714
17. Lewis AJ, Galbally M, Opie G, Buist A: Neonatal growth outcomes at birth and one month postpartum following in utero exposure to antidepressant medication. Aust NZ J Psychiatry 2010; 44: 482-487
18. Davidson S, Prokonov D, Taler M, Maayan R, Harell D, Gil-Ad I, Weizman A: Effect of exposure to selective serotonin reuptake inhibitors in utero on fetal growth: potential role for the IGF-I and HPA axes. Pediatr Res 2009; 65: 236-241
19. Dubnov-Raz G, Hemilä H, Vurembrand Y, Kuint J, Maayan- Metzger A: Maternal use of selective serotonin reuptake inhibitors during pregnancy and neonatal bone density. Early Hum Dev 2012; 88: 191-194
20. Centers for Disease Control and Prevention: A SAS Program for the CDC Growth Charts, 2011. http://www.cdc.gov/nccdphp/dnpao/growthcharts/resources/ sas.htm
21. Centers for Disease Control and Prevention: Breastfeeding among US children born 1999-2005, CDC National Immunization Survey. http://www.cdc.gov/ breastfeeding/data/nis-data/
22. Chambers CD, Anderson PO, Thomas RG, Dick LM, Felix RJ, Johnson KA, Jones KL: Weight gain in infants breastfed by mothers who take fluoxetine. Pediatrics 1999; 104:e61
23. Wisner KL, Zarin DA, Holmboe ES, Appelbaum PS, Gelenberg AJ, Leonard HL, Frank E: Risk-benefit decision making for treatment of depression during pregnancy. Am J Psychiatry 2000; 157: 1933-1940
24. Barker DJ, Osmond C, Golding J, Kuh D, Wadsworth ME: Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ 1989; 298: 564-567
25. Harder T, Rodekamp E, Schellong K, Dudenhausen JW, Plagemann A: Birth weight and subsequent risk of type 2 diabetes: a metaanalysis. Am J Epidemiol 2007; 165: 849-857
26. Williams J, Terman M: Structured Interview Guide for the Hamilton Depression Rating Scale With Atypical Depression Supplement (SIGH-ADS). New York, New York State Psychiatric Institute, 2003
27. Raju TN, Higgins RD, Stark AR, Leveno KJ: Optimizing care and outcome for late-preterm (near-term) infants: a summary of the workshop sponsored by the National Institute of Child Health and Human Development. Pediatrics 2006; 118: 1207-1214
28. O'Hara MW, Varner MW, Johnson SR: Assessing stressful life events associated with childbearing: the Peripartum Events Scale. J Reprod Infant Psychol 1986; 4: 85-98
29. Post RM, Roy-Byrne PP, Uhde TW: Graphic representation of the life course of illness in patients with affective disorder. Am J Psychiatry 1988; 145: 844-848
30. Keller MB, Lavori PW, Friedman B, Nielsen E, Endicott J, McDonald-Scott P, Andreasen NC: The Longitudinal Interval Follow-Up Evaluation: a comprehensive method for assessing outcome in prospective longitudinal studies. Arch Gen Psychiatry 1987; 44: 540-548
31. Regier DA, Rae DS, Narrow WE, Kaelber CT, Schatzberg AF: Prevalence of anxiety disorders and their comorbidity with mood and addictive disorders. Br J Psychiatry Suppl 1998; 173 (suppl 34): 24-28
32. Dunkel Schetter C, Tanner L: Anxiety, depression and stress in pregnancy: implications for mothers, children, research, and practice. Curr Opin Psychiatry 2012; 25: 141-148
33. Hosseini SM, Biglan MW, Larkby C, Brooks MM, Gorin MB, Day NL: Trait anxiety in pregnant women predicts offspring birth outcomes. Paediatr Perinat Epidemiol 2009; 23: 557-566
34. Wisner KL: The last therapeutic orphan: the pregnant woman. Am J Psychiatry 2012; 169: 554-556
35. Lyerly AD, Mitchell LM, Armstrong EM, Harris LH, Kukla R, Kuppermann M, Little MO: Risks, values, and decision making surrounding pregnancy. Obstet Gynecol 2007; 109: 979-984
36. Hunter SK, Mendoza JH, D'Anna K, Zerbe GO, McCarthy L, Hoffman C, Freedman R, Ross RG: Antidepressants may mitigate the effects of prenatal maternal anxiety on infant auditory sensory gating. Am J Psychiatry 2012; 169: 616-624